-- 周四盘前，医疗保健类股涨跌互现，道富医疗保健精选行业SPDR ETF (XLV)下跌0.1%，而iShares生物科技ETF (IBB)上涨0.1%。 Cytokinetics (CYTK)股价在盘前下跌超过1%，此前该公司周三晚间宣布，其规模扩大的公开发行定价为每股71美元，发行约990万股，总募资额约为7亿美元。 Catalyst Pharmaceuticals (CPRX)股价在开盘前上涨超过2%，此前该公司同意被Angelini Pharma以约41亿美元的股权价值收购。该公司还表示，已与Hetero Labs达成和解协议，以解决关于Firdapse（氨吡啶）仿制药的专利诉讼。 Lifestance Health Group (LFST)股价上涨11%，此前该公司公布了第一季度盈利和营收双双增长的业绩。
Related Articles
Mining & Metals
Canadian Natural Resources Maintained at Hold at TPH After Q1 Results; Price Target at C$70.00
Tudor, Pickering, Holt on Thursday maintained its hold rating on the shares of Canadian Natural Resources (CNQ.TO, CNQ) with a C$70.00 price target following first-quarter results from the country's No.1 oil producer."While generally expected given net debt levels exiting 2025, highlights from the overall update include the formal step-up in return-of-capital alongside the ~4% beat on Q1 cash flow. On Q1 results, headline metrics include C$4.37B AFFO vs. TPHe/Street consensus C$4.19B/C$4.26B (C$2.09/shr vs. TPHe/Street C$2.01/C$2.01), with the delta vs. our model owing to realizations and expenses more than offsetting production. 1,643mboepd came in slightly below TPHe/Street 1,657/1,651, primarily driven by Oil Sands with 275mbopd In Situ comparing to TPHe/Street 279/276 and 588mbopd OSM comparing to TPHe/Street 594/595, though the April run-rate within OSM of 630mbopd bodes well for Q2 (TPHe/Street 587/587). On the balance sheet and return of capital, net debt is now sufficiently below C$16B to have driven CNQ to plan for returning 75% of FCF to shareholders. This is already starting to take effect, with April buybacks already totaling ~$0.3B, matching full Q1's buyback activity ($1.5B in return of capital, consisting of $1.2B in dividends and $0.3B in share repurchases); no change to TPHe H2'27+ at strip for the final uplift to 100% with ND (covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $59.80, Change: $-2.46, Percent Change: -3.95%
$CNQ$CNQ.TO
Insider Trading
Hometrust Bancshares Insider Sold Shares Worth $1,654,419, According to a Recent SEC Filing
Hunter Westbrook, Director, President, CEO, on May 05, 2026, sold 36,096 shares in Hometrust Bancshares (HTB) for $1,654,419. Following the Form 4 filing with the SEC, Westbrook has control over a total of 122,604 common shares of the company, with 105,828 shares held directly and 16,776 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1538263/000153826326000048/xslF345X05/wk-form4_1778166405.xmlPrice: $46.15, Change: $+0.20, Percent Change: +0.42%
$HTB
Asia Markets
European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading
European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, losing 0.87% to 1,830.89 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and accommodations booking company trivago (TRVG), which advanced 12% and 8%, respectively. They were followed by internet advertising firm Criteo (CRTO) and software company SAP (SAP), which increased 3.8% and 3.5%, respectively.The decliners from continental Europe were led by telecommunications company Nokia (NOK) and petroleum refiner Equinor (EQNR), which fell 4.4% and 4.3%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Ascendis Pharma (ASND), which were down 2.7% and 2.3% respectively.The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which rose 5.3% and 3.8% respectively. They were followed by communications company WPP (WPP) and hospitality company InterContinental Hotels Group (IHG), which were up 2.7% and 2.3% respectively.The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which lost 4.9% and 3.2% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and oil and gas company Shell (SHEL), which dropped 2.7% and 2.6% respectively.
$AKTX$ASND$AUTL$BCYC$BDRX$CRTO$EDAP$EQNR$IHG$NOK$SAP$SHEL$SLN$SQNS$TRVG$WPP